RxDoctor Payments Data

David Fang, MD

Otolaryngology · Indianapolis, INNPI 1174670657

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 141 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by Regeneron Healthcare Solutions, Inc. at 31.6% of the total.

$2,836in general payments, 2019–2025

Across 141 payments — averaging $20.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron Healthcare Solutions, Inc.$895
  • GSK$665
  • Sanofi$252
  • Optinose US, Inc.$213
  • Aerin Medical Inc.$184
  • Acclarent, Inc$157
  • plus $469 from 15 others

What the payments were for

  • Food & beverage$2,836100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,836 in reported general payments places this provider in the 70th percentile of 193 otolaryngology providers in Indiana.

See all otolaryngology providers in Indiana

Medicare billing

Part B allowed, 2024
$51,673
Medicare patients
299
Services billed
1,084

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth27$1,751
Dexamethasone Sodium Phosphate28$976
Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort11$575
Ciprofloxacin Hcl53$529
Ipratropium Bromide14$342
Omeprazole15$158
Methylprednisolone27$145
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen20$134
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav12$103
Ondansetron OdtOndansetron17$73
Cephalexin16$64

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Indianapolis

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →